America Needs This Company
This stock might just be one of America's No.1 tech investments this year.

NYSE:PFE - Pfizer Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $41.77
  • Forecasted Upside: -2.61 %
  • Number of Analysts: 13
  • Breakdown:
  • 0 Sell Ratings
  • 11 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$42.89
▲ +0.79 (1.88%)

This chart shows the closing price for PFE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Pfizer Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PFE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PFE

Analyst Price Target is $41.77
▼ -2.61% Downside Potential
This price target is based on 13 analysts offering 12 month price targets for Pfizer in the last 3 months. The average price target is $41.77, with a high forecast of $45.00 and a low forecast of $39.00. The average price target represents a -2.61% upside from the last price of $42.89.

This chart shows the closing price for PFE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
Peter Thiel Bets Big On "Mushroom Boom."
LSD and "Mushroom stocks" are being listed on the NASDAQ and a recent breakthrough makes top investors VERY excited about the coming "Mushroom Boom."

Current Consensus is Hold

The current consensus among 13 polled investment analysts is to hold stock in Pfizer. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 2 buy ratings
  • 9 hold ratings
  • 0 sell ratings
2/3/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 9 hold ratings
  • 0 sell ratings
5/3/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 9 hold ratings
  • 0 sell ratings
8/1/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 10 hold ratings
  • 0 sell ratings
10/30/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 11 hold ratings
  • 0 sell ratings
1/28/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 11 hold ratings
  • 0 sell ratings
4/28/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 11 hold ratings
  • 0 sell ratings
6/27/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 11 hold ratings
  • 0 sell ratings
7/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 11 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/27/2021TruistInitiated CoverageBuy$43.00High
6/17/2021Royal Bank of CanadaBoost Price TargetSector Perform$43.00 ➝ $44.00Low
6/15/2021Berenberg BankReiterated RatingNeutral$43.00Low
5/24/2021JPMorgan Chase & Co.Set Price TargetNeutral$40.00Low
5/24/2021The Goldman Sachs GroupSet Price TargetNeutral$45.00Low
5/13/2021The Goldman Sachs GroupReiterated RatingNeutral$45.11Low
5/12/2021MizuhoReiterated RatingBuy ➝ Neutral$42.00Low
5/10/2021Morgan StanleyBoost Price TargetEqual Weight$38.00 ➝ $42.00Low
5/6/2021MizuhoDowngradeBuy ➝ Neutral$42.00Low
5/5/2021SVB LeerinkBoost Price TargetMarket Perform$39.00 ➝ $43.00High
5/5/2021JPMorgan Chase & Co.Boost Price TargetNeutral$36.00 ➝ $40.00Medium
5/5/2021BarclaysBoost Price TargetEqual Weight$37.00 ➝ $40.00Medium
4/7/2021Royal Bank of CanadaInitiated CoverageSector Perform$42.00Low
4/6/2021The Goldman Sachs GroupSet Price TargetNeutral$41.00Low
3/31/2021The Goldman Sachs GroupSet Price TargetNeutral$41.00Low
3/26/2021SVB LeerinkLower Price TargetMarket Perform$40.00 ➝ $39.00Medium
3/23/2021Berenberg BankReiterated RatingNeutral$38.00Medium
3/15/2021The Goldman Sachs GroupSet Price TargetNeutral$41.00Medium
3/9/2021The Goldman Sachs GroupReiterated RatingNeutral$41.00Low
2/3/2021JPMorgan Chase & Co.Set Price TargetNeutral$36.00Low
2/3/2021DZ BankReiterated RatingHold ➝ Buy$41.00Low
2/3/2021SVB LeerinkLower Price TargetMarket Perform$44.00 ➝ $40.00Low
2/3/2021MizuhoLower Price TargetBuy$44.00 ➝ $42.00Low
1/29/2021Morgan StanleyLower Price TargetEqual Weight$40.00 ➝ $38.00Medium
1/21/2021The Goldman Sachs GroupSet Price TargetNeutral$40.00Low
1/8/2021The Goldman Sachs GroupSet Price TargetNeutral$40.00Low
1/4/2021Royal Bank of CanadaSet Price TargetNeutral$42.00N/A
12/29/2020Royal Bank of CanadaReiterated RatingNeutral$42.00N/A
12/16/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$43.00 ➝ $42.00N/A
12/11/2020The Goldman Sachs GroupSet Price TargetNeutral$40.00Low
12/4/2020BarclaysBoost Price TargetEqual Weight$35.00 ➝ $37.00Low
12/2/2020BarclaysSet Price TargetNeutral$35.00Medium
12/2/2020Royal Bank of CanadaSet Price TargetBuy$43.00Low
12/2/2020The Goldman Sachs GroupSet Price TargetNeutral$40.00Low
11/19/2020The Goldman Sachs GroupInitiated CoverageNeutral$40.00Medium
11/10/2020Sanford C. BernsteinInitiated CoverageMarket Perform$42.00High
11/10/2020MizuhoBoost Price TargetBuy$43.00 ➝ $44.00High
11/9/2020BarclaysReiterated RatingNeutral$35.00High
11/9/2020JPMorgan Chase & Co.Set Price TargetNeutral$36.00High
10/28/2020SVB LeerinkBoost Price TargetMarket Perform$42.00 ➝ $43.00High
10/23/2020TruistInitiated CoverageBuy$42.00Low
10/16/2020Royal Bank of CanadaSet Price TargetBuy$43.00Low
10/12/2020Atlantic SecuritiesDowngradeOverweight ➝ Neutral$44.00 ➝ $39.00Low
9/29/2020Berenberg BankInitiated CoverageHold$38.00Low
9/15/2020MizuhoReiterated RatingBuy$43.00Low
9/9/2020Royal Bank of CanadaSet Price TargetBuy$43.00Low
7/30/2020Morgan StanleyBoost Price TargetEqual Weight$36.00 ➝ $42.00Low
7/29/2020UBS GroupBoost Price TargetNeutral$37.00 ➝ $39.00Low
7/29/2020SVB LeerinkBoost Price TargetMarket Perform$39.00 ➝ $42.00Low
7/28/2020MizuhoReiterated RatingPositive ➝ Buy$38.00Low
7/21/2020Morgan StanleyReiterated RatingHold$36.00High
7/20/2020Royal Bank of CanadaReiterated RatingBuy$43.00High
6/29/2020MizuhoInitiated CoverageBuy$38.00Low
6/26/2020Piper SandlerBoost Price Target$18.50 ➝ $24.00Medium
6/16/2020SVB LeerinkInitiated CoverageMarket Perform$40.00Low
6/1/2020BarclaysLower Price Target$37.00 ➝ $35.00Medium
6/1/2020JPMorgan Chase & Co.Lower Price TargetNeutral$37.00 ➝ $36.00High
5/18/2020MizuhoReiterated RatingBuy$42.00Low
4/29/2020BarclaysBoost Price TargetEqual Weight$36.00 ➝ $37.00Low
4/27/2020Royal Bank of CanadaReiterated RatingBuy$44.00Medium
4/26/2020MizuhoReiterated RatingBuy$42.00High
4/2/2020Morgan StanleyLower Price TargetEqual Weight$43.00 ➝ $36.00Medium
3/27/2020Royal Bank of CanadaLower Price TargetOutperform$46.00 ➝ $44.00Low
3/19/2020Cantor FitzgeraldReiterated RatingBuy$53.00High
3/18/2020MizuhoReiterated RatingBuy$42.00High
2/27/2020Standpoint ResearchUpgradeHold ➝ BuyHigh
2/27/2020BarclaysInitiated CoverageEqual Weight$36.00Medium
2/5/2020MizuhoInitiated CoverageBuy$42.00Low
1/29/2020Cantor FitzgeraldReiterated RatingBuy$53.00Low
1/28/2020JPMorgan Chase & Co.Reiterated RatingNeutral$37.00Low
1/6/2020Royal Bank of CanadaInitiated CoverageOutperform$46.00Medium
11/6/2019Credit Suisse GroupReiterated RatingHold$41.30Low
10/29/2019JPMorgan Chase & Co.Reiterated RatingNeutralHigh
10/16/2019Bank of AmericaInitiated CoverageNeutral$37.00Low
9/19/2019JPMorgan Chase & Co.Boost Price TargetNeutral$37.00 ➝ $46.00Low
8/28/2019DZ BankUpgradeSell ➝ Hold$36.00Medium
8/27/2019Morgan StanleyLower Price TargetEqual Weight$40.00 ➝ $38.00High
8/27/2019DZ BankReiterated RatingHold ➝ NeutralMedium
8/12/2019Credit Suisse GroupReiterated RatingHold ➝ NeutralHigh
8/5/2019UBS GroupReiterated RatingNeutral$43.00High
7/30/2019Bank of AmericaDowngradeBuy ➝ NeutralHigh
7/30/2019Morgan StanleyDowngradeOverweight ➝ Equal Weight$48.00 ➝ $40.00High
7/29/2019JPMorgan Chase & Co.Set Price TargetNeutral$46.00High
7/23/2019JPMorgan Chase & Co.Reiterated RatingNeutral$46.00Low
7/15/2019Credit Suisse GroupInitiated CoverageHold$47.00Low
6/17/2019Credit Suisse GroupReiterated RatingBuy$48.00Low
6/17/2019The Goldman Sachs GroupReiterated RatingBuy$49.00Low
6/17/2019JPMorgan Chase & Co.Reiterated RatingHold$46.00Low
6/4/2019Morgan StanleyInitiated CoverageOverweight ➝ Overweight$48.00Low
5/28/2019The Goldman Sachs GroupInitiated CoverageConviction-BuyLow
5/9/2019BarclaysReiterated RatingHold$41.00Low
5/6/2019Credit Suisse GroupReiterated RatingBuy$48.00Medium
4/30/2019JPMorgan Chase & Co.Set Price TargetNeutral$46.00Low
4/19/2019JPMorgan Chase & Co.Reiterated RatingNeutral$46.00N/A
4/1/2019Bank of AmericaBoost Price TargetBuy ➝ Buy$45.00 ➝ $48.00Low
2/20/2019CitigroupReiterated RatingSell ➝ Neutral$41.00Medium
2/19/2019Cantor FitzgeraldReiterated RatingBuy$53.00Low
1/31/2019ArgusUpgradeHold ➝ Buy$55.00Medium
1/31/2019Credit Suisse GroupUpgradeNeutral ➝ OutperformMedium
1/28/2019Credit Suisse GroupReiterated RatingNeutral$45.00High
1/23/2019UBS GroupDowngradeBuy ➝ NeutralLow
1/1/2019Credit Suisse GroupSet Price TargetNeutral$45.00Medium
12/30/2018Cantor FitzgeraldSet Price TargetBuy$53.00Low
12/26/2018Credit Suisse GroupSet Price TargetNeutral$45.00High
12/20/2018Credit Suisse GroupReiterated RatingNeutral$45.00Low
12/13/2018Credit Suisse GroupSet Price TargetHold$45.00Medium
12/11/2018Cantor FitzgeraldReiterated RatingBuy$53.00Low
12/11/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$46.00Low
11/27/2018Atlantic SecuritiesReiterated RatingBuy$54.00Medium
11/26/2018Credit Suisse GroupSet Price TargetHold$42.00Medium
11/19/2018Cantor FitzgeraldReiterated RatingBuy$53.00Low
11/8/2018Cantor FitzgeraldSet Price TargetBuy$53.00Low
11/6/2018CitigroupBoost Price TargetSell ➝ Sell$34.00 ➝ $37.00Medium
11/1/2018BMO Capital MarketsDowngradeOutperform ➝ Market Perform$47.00 ➝ $46.00Medium
11/1/2018Societe GeneraleSet Price TargetHold$43.00Medium
10/30/2018Credit Suisse GroupReiterated RatingNeutral ➝ Neutral$40.00Low
10/30/2018The Goldman Sachs GroupReiterated RatingNeutral$45.00Low
10/30/2018JPMorgan Chase & Co.Reiterated RatingBuyLow
10/23/2018Wolfe ResearchInitiated CoverageMarket PerformLow
10/19/2018BarclaysSet Price TargetNeutral$40.00Low
10/17/2018Cantor FitzgeraldReiterated RatingBuy$53.00Low
10/14/2018Credit Suisse GroupSet Price TargetHold$40.00Low
10/9/2018MorningstarSet Price TargetNeutral$46.00Low
10/4/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
10/4/2018Independent ResearchSet Price TargetNeutral$48.00Low
10/1/2018JPMorgan Chase & Co.Set Price TargetBuy$46.00Low
9/27/2018MorningstarSet Price TargetBuy$46.00Low
9/26/2018BarclaysReiterated RatingNeutral$40.00Low
9/26/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
9/13/2018Morgan StanleySet Price TargetBuy$45.00Medium
9/13/2018Cantor FitzgeraldSet Price TargetBuy$45.00Medium
9/10/2018JPMorgan Chase & Co.Set Price TargetBuy$42.00Medium
9/7/2018BMO Capital MarketsBoost Price TargetOutperform$47.00Medium
9/6/2018Credit Suisse GroupSet Price TargetHold$40.00Low
9/6/2018Morgan StanleySet Price TargetBuy$45.00Low
8/29/2018BarclaysSet Price TargetNeutral$40.00Low
8/29/2018Morgan StanleySet Price TargetBuy$45.00Low
8/28/2018Credit Suisse GroupSet Price TargetNeutral$40.00Low
8/28/2018The Goldman Sachs GroupReiterated RatingNeutral$45.00Low
8/28/2018MorningstarSet Price TargetBuy$46.00Low
8/27/2018BMO Capital MarketsReiterated RatingBuy$44.00Low
8/27/2018Cantor FitzgeraldSet Price TargetBuy$45.00High
8/23/2018JPMorgan Chase & Co.Reiterated RatingBuy$42.00Low
8/23/2018BarclaysBoost Price TargetEqual Weight ➝ Neutral$38.00 ➝ $40.00Low
8/23/2018Morgan StanleySet Price TargetOverweight ➝ Buy$43.00 ➝ $45.00Low
8/21/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy$42.00 ➝ $45.00Low
8/13/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
8/10/2018SunTrust BanksBoost Price TargetHold$41.00Low
8/8/2018MorningstarSet Price TargetBuy$45.00Low
8/1/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$42.00 ➝ $43.00Low
8/1/2018The Goldman Sachs GroupReiterated RatingNeutral$42.00Low
8/1/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$42.00 ➝ $44.00Medium
8/1/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$39.00 ➝ $40.00Medium
7/31/2018Jefferies Financial GroupSet Price TargetNeutral$39.00High
7/31/2018JPMorgan Chase & Co.Reiterated RatingBuyHigh
7/31/2018Credit Suisse GroupSet Price TargetHold$39.00High
7/31/2018Cantor FitzgeraldSet Price TargetBuy$45.00High
7/19/2018BMO Capital MarketsReiterated RatingBuy$42.00Low
7/18/2018JPMorgan Chase & Co.Reiterated Rating$37.66Medium
7/18/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
7/15/2018Jefferies Financial GroupSet Price TargetHold$39.00Low
7/12/2018Credit Suisse GroupSet Price TargetNeutral$39.00Low
7/11/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
7/11/2018JPMorgan Chase & Co.Reiterated RatingBuy$42.00Low
7/9/2018Jefferies Financial GroupReiterated RatingNeutral$39.00Medium
6/13/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
6/11/2018Morgan StanleyReiterated RatingBuy$43.00Low
6/11/2018Credit Suisse GroupSet Price TargetNeutral$39.00Low
6/7/2018Cantor FitzgeraldInitiated CoverageOverweight$45.00Low
5/30/2018Societe GeneraleReiterated RatingNeutral$39.00Low
5/18/2018Credit Suisse GroupReiterated RatingNeutral$39.00Low
5/14/2018Jefferies Financial GroupReiterated RatingNeutral$39.00Low
5/8/2018JPMorgan Chase & Co.Set Price TargetBuy$42.00Low
5/3/2018DZ BankReiterated RatingSellLow
5/2/2018MorningstarSet Price TargetBuy$43.50Low
5/2/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$43.00 ➝ $42.00Low
5/2/2018JPMorgan Chase & Co.Reiterated RatingBuy$42.00Medium
4/13/2018Jefferies Financial GroupSet Price TargetHold$38.00Low
4/12/2018CitigroupReiterated RatingSellMedium
4/11/2018Berenberg BankReiterated RatingNeutral$37.00Low
4/5/2018BarclaysDowngradeOverweight ➝ Equal Weight$41.00 ➝ $38.00Medium
4/2/2018BMO Capital MarketsSet Price TargetBuy$43.00Medium
3/6/2018BMO Capital MarketsSet Price TargetBuy$43.00Low
2/26/2018Jefferies Financial GroupSet Price TargetHold$39.00Low
2/15/2018BMO Capital MarketsSet Price TargetBuy$43.00Low
2/5/2018BMO Capital MarketsSet Price TargetBuy$43.00High
1/31/2018BarclaysBoost Price TargetOverweight ➝ Overweight$38.00 ➝ $41.00Medium
1/31/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$37.00 ➝ $39.00Medium
1/31/2018SVB LeerinkBoost Price TargetMarket Perform ➝ Market Perform$35.00 ➝ $38.00Medium
1/31/2018UBS GroupSet Price TargetBuy$42.00Medium
1/31/2018Morgan StanleyBoost Price TargetOverweight ➝ Buy$41.00 ➝ $43.00Medium
1/31/2018Societe GeneraleSet Price TargetNeutral$40.00Medium
1/30/2018The Goldman Sachs GroupSet Price TargetNeutral$36.00High
1/30/2018MorningstarSet Price TargetNeutral$38.00High
1/30/2018Bank of AmericaSet Price TargetBuy$40.00Medium
1/30/2018JPMorgan Chase & Co.Reiterated RatingBuyLow
1/30/2018Sanford C. BernsteinSet Price TargetBuy$43.00Low
1/30/2018Berenberg BankSet Price TargetNeutral$36.00Low
1/30/2018BMO Capital MarketsSet Price TargetBuy$39.00High
1/29/2018SunTrust BanksReiterated RatingHold ➝ Hold$33.00 ➝ $40.00Low
1/24/2018BMO Capital MarketsSet Price TargetBuy$39.00Low
1/16/2018Jefferies Financial GroupSet Price TargetNeutral$40.00Low
1/8/2018BMO Capital MarketsSet Price TargetBuy$39.00Low
1/5/2018Morgan StanleySet Price TargetBuy$41.00Low
1/2/2018Nord/LBReiterated RatingNeutralLow
12/27/2017Nord/LBReiterated RatingNeutralLow
12/15/2017BMO Capital MarketsSet Price TargetBuy$39.00Low
12/8/2017BMO Capital MarketsSet Price TargetBuy$39.00Low
12/6/2017UBS GroupSet Price TargetBuy$40.00Low
12/6/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$38.00Low
11/25/2017BMO Capital MarketsSet Price TargetBuy$39.00Low
11/16/2017Jefferies Financial GroupSet Price TargetNeutral$39.00N/A
11/10/2017BMO Capital MarketsReiterated RatingBuy$39.00N/A
11/1/2017JPMorgan Chase & Co.Set Price TargetBuy$39.00N/A
11/1/2017Jefferies Financial GroupSet Price TargetNeutral$39.00N/A
11/1/2017The Goldman Sachs GroupSet Price TargetNeutral$36.00N/A
11/1/2017UBS GroupSet Price TargetBuy$38.00N/A
10/31/2017Berenberg BankSet Price TargetNeutral$36.00N/A
10/31/2017BMO Capital MarketsSet Price TargetBuy$39.00N/A
10/26/2017Jefferies Financial GroupSet Price TargetNeutral$39.00N/A
10/19/2017BMO Capital MarketsReiterated RatingBuy$37.00 ➝ $39.00N/A
10/16/2017Jefferies Financial GroupSet Price TargetNeutral$38.00N/A
10/11/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$38.00N/A
10/11/2017BarclaysSet Price TargetBuy$38.00N/A
10/10/2017BMO Capital MarketsSet Price TargetBuy$37.00N/A
9/20/2017Morgan StanleyUpgradeEqual Weight ➝ Overweight$35.00 ➝ $39.00Low
9/19/2017Sanford C. BernsteinSet Price TargetBuy$39.00Low
9/18/2017Jefferies Financial GroupSet Price TargetNeutral$37.00Low
9/14/2017BMO Capital MarketsReiterated RatingBuy$37.00High
9/6/2017BMO Capital MarketsReiterated RatingBuy$37.00Low
8/24/2017Jefferies Financial GroupSet Price TargetNeutral$35.00Low
8/18/2017Jefferies Financial GroupReiterated RatingHold$35.00Low
8/15/2017Berenberg BankReiterated RatingHold$39.00 ➝ $36.00Low
8/14/2017CowenSet Price TargetBuy$43.00Low
8/2/2017Jefferies Financial GroupSet Price TargetNeutral$35.00Low
8/2/2017BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$33.00 ➝ $37.00Low
8/1/2017Berenberg BankSet Price TargetNeutral$39.00Low
7/31/2017UBS GroupReiterated RatingBuy$38.00Medium
7/20/2017Credit Suisse GroupDowngradeOutperform ➝ Neutral$38.00 ➝ $36.00Low
7/17/2017Sanford C. BernsteinSet Price TargetBuy$39.00Low
7/14/2017Jefferies Financial GroupReiterated RatingHold$34.00 ➝ $35.00Low
7/10/2017CowenSet Price TargetBuy$43.00Low
6/16/2017Jefferies Financial GroupReiterated RatingNeutral$34.00Low
6/12/2017Morgan StanleyReiterated RatingNeutral$38.00 ➝ $35.00Low
5/16/2017CitigroupDowngradeNeutral ➝ Sell$38.00 ➝ $31.00Low
5/3/2017BarclaysReiterated RatingBuy$38.00Low
5/3/2017Sanford C. BernsteinReiterated RatingBuy$37.00Low
4/27/2017BMO Capital MarketsReiterated RatingHold$33.00Low
4/24/2017Sanford C. BernsteinReiterated RatingBuy$35.00Low
4/13/2017Jefferies Financial GroupReiterated RatingNeutral$34.00 ➝ $35.00Low
4/6/2017Morgan StanleyReiterated RatingNeutral$38.00Low
3/24/2017Sanford C. BernsteinReiterated RatingBuy$35.00Low
3/23/2017Societe GeneraleReiterated RatingNeutral$36.00Low
3/21/2017BMO Capital MarketsReiterated RatingHold$33.00Low
3/16/2017BarclaysSet Price TargetBuy$38.00Low
3/14/2017UBS GroupReiterated RatingBuy$38.00N/A
3/13/2017Sanford C. BernsteinSet Price TargetBuy$35.00Low
3/13/2017Credit Suisse GroupSet Price TargetBuy$38.00Low
3/9/2017Jefferies Financial GroupSet Price TargetNeutral$34.00Low
2/17/2017Jefferies Financial GroupSet Price TargetNeutral$34.00N/A
2/17/2017Berenberg BankSet Price TargetNeutral$39.00N/A
2/16/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$40.00N/A
2/2/2017MorningstarReiterated RatingBuyN/A
2/1/2017Atlantic SecuritiesSet Price TargetBuy$37.00N/A
1/30/2017BMO Capital MarketsReiterated RatingMarket Perform$33.00N/A
1/24/2017Sanford C. BernsteinSet Price TargetBuy$35.00N/A
1/21/2017Piper Jaffray CompaniesSet Price TargetBuy$53.00N/A
1/19/2017Jefferies Financial GroupReiterated RatingHold$30.00N/A
1/18/2017The Goldman Sachs GroupSet Price TargetNeutral$36.00N/A
12/20/2016Credit Suisse GroupReiterated RatingBuy$38.00N/A
12/19/2016Jefferies Financial GroupReiterated RatingHold$30.00N/A
12/7/2016Sanford C. BernsteinReiterated RatingOverweightN/A
12/2/2016GuggenheimInitiated CoverageNeutralN/A
11/30/2016BMO Capital MarketsSet Price TargetHold$33.00N/A
11/29/2016BarclaysUpgradeEqual Weight ➝ Overweight$38.00N/A
11/11/2016Jefferies Financial GroupSet Price TargetNeutral$34.00N/A
11/7/2016Bank of AmericaReiterated RatingBuy$40.00 ➝ $36.00N/A
11/3/2016Atlantic SecuritiesSet Price TargetBuy$35.00N/A
11/2/2016ArgusDowngradeBuy ➝ HoldN/A
11/2/2016BMO Capital MarketsDowngradeOutperform ➝ Market Perform$40.00 ➝ $33.00N/A
11/1/2016Berenberg BankSet Price TargetNeutral$38.00N/A
11/1/2016Sanford C. BernsteinSet Price TargetBuy$36.00N/A
10/19/2016Sanford C. BernsteinSet Price TargetBuy$36.00N/A
10/18/2016BMO Capital MarketsReiterated RatingOutperform$40.00N/A
10/13/2016Jefferies Financial GroupDowngradeBuy ➝ Hold$39.00 ➝ $36.00N/A
10/4/2016ArgusReiterated RatingBuy$39.00N/A
9/30/2016UBS GroupSet Price TargetBuy$38.00N/A
9/27/2016Bank of AmericaReiterated RatingBuy$40.00N/A
9/26/2016Sanford C. BernsteinReiterated RatingOutperformN/A
9/13/2016Jefferies Financial GroupLower Price TargetBuy$40.00 ➝ $39.00N/A
9/7/2016UBS GroupReiterated RatingBuyN/A
8/28/2016ArgusReiterated RatingBuy$39.00N/A
8/25/2016Jefferies Financial GroupSet Price TargetBuy$40.00N/A
8/23/2016Piper Jaffray CompaniesSet Price TargetBuy$54.00N/A
8/23/2016BMO Capital MarketsReiterated RatingOutperform$40.00N/A
8/22/2016Bank of AmericaSet Price TargetBuy$40.00N/A
8/22/2016Credit Suisse GroupReiterated RatingOutperform$40.00N/A
8/18/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$44.00N/A
8/3/2016JPMorgan Chase & Co.Set Price TargetBuy$40.00N/A
8/3/2016CitigroupReiterated RatingNeutral$37.00N/A
8/2/2016BarclaysReiterated RatingEqual Weight$34.00N/A
8/2/2016Sanford C. BernsteinSet Price TargetBuy$38.00N/A
8/1/2016Jefferies Financial GroupSet Price TargetBuy$41.50 ➝ $40.00N/A
(Data available from 7/28/2016 forward)
Pfizer logo
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Read More

Today's Range

Now: $42.89
Low: $41.68
High: $43.25

50 Day Range

MA: $39.68
Low: $38.50
High: $42.10

52 Week Range

Now: $42.89
Low: $33.36
High: $43.08

Volume

788,676 shs

Average Volume

28,770,240 shs

Market Capitalization

$240.09 billion

P/E Ratio

21.88

Dividend Yield

3.73%

Beta

0.74

Frequently Asked Questions

What sell-side analysts currently cover shares of Pfizer?

The following Wall Street analysts have issued reports on Pfizer in the last twelve months: Atlantic Securities, Barclays PLC, Berenberg Bank, DZ Bank AG, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Royal Bank of Canada, Sanford C. Bernstein, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Truist, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for PFE.

What is the current price target for Pfizer?

13 Wall Street analysts have set twelve-month price targets for Pfizer in the last year. Their average twelve-month price target is $41.77, suggesting a possible downside of 0.8%. The Goldman Sachs Group, Inc. has the highest price target set, predicting PFE will reach $45.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $39.00 for Pfizer in the next year.
View the latest price targets for PFE.

What is the current consensus analyst rating for Pfizer?

Pfizer currently has 11 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PFE, but not buy more shares or sell existing shares.
View the latest ratings for PFE.

What other companies compete with Pfizer?

How do I contact Pfizer's investor relations team?

Pfizer's physical mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company's listed phone number is (212) 733-2323. The official website for Pfizer is www.pfizer.com.

Peter Thiel Bets Big On "Mushroom Boom."
LSD and "Mushroom stocks" are being listed on the NASDAQ and a recent breakthrough makes top investors VERY excited about the coming "Mushroom Boom."